Structure Therapeutics Inc. (GPCR)
NASDAQ: GPCR · Real-Time Price · USD
26.68
-0.79 (-2.88%)
At close: Oct 7, 2026, 4:00 PM EDT
27.54
+0.86 (3.22%)
After-hours: Oct 7, 2026, 7:47 PM EDT
Structure Therapeutics Market Cap
Structure Therapeutics has a market cap or net worth of $1.9 billion as of October 7, 2026. That makes Structure Therapeutics the world's 7,009th most valuable company and 1,815th in the United States. Its market cap has increased by 15.17% in one year.
Market Cap
1.90B
Enterprise Value
566.12M
1-Year Change
15.17%
Global Rank
Country Rank
#1,815 United States
Category
ChartMarket Cap Chart
Since the IPO on February 3, 2023, Structure Therapeutics's market cap has increased from $548.82M to $1.90B, an increase of 246.66%. That is a compound annual growth rate of 40.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 7, 2026 | 1.90B | -60.43% |
| Dec 31, 2025 | 4.81B | 209.65% |
| Dec 31, 2024 | 1.55B | -22.02% |
| Dec 29, 2023 | 1.99B | 262.83% |
| Feb 3, 2023 | 548.82M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Fortrea Holdings | 1.96B |
| Mineralys Therapeutics | 1.95B |
| Vir Biotechnology | 1.95B |
| ADARx Pharmaceuticals | 1.94B |
| Maravai LifeSciences Holdings | 1.93B |
| Agios Pharmaceuticals | 1.90B |
| Zymeworks | 1.88B |
| Palvella Therapeutics | 1.88B |